Celgene, Bluebird, and J&J out with early but telling data in blood cancer

Celgene, Bluebird, and J&J out with early but telling data in blood cancer

STAT Plus: ASH preview: Celgene, Bluebird, and J&J out with early but telling data in blood cancer

By ADAM FEUERSTEIN

WILLIAM R. GEDDIE VIA WELLCOME

Important new data on closely followed blood cancer treatments emerged in research abstracts released by the American Society of Hematology.

READ MORE